← United States · Coverage record
US · SEC FORM 4
Imunon, Inc.
IMNN · Nasdaq · CIK 0000749647 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
53 Form 4 transaction lines observed in the same window
6 sales · 47 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-08-20 · Braun Donald P.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 173,197
- Previous report
- 193,639
- Avg daily volume
- 142,353
- Days to cover
- 1.2
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2024-08-20 | Braun Donald P | Purchase (P) | Common Stock | 25,000 | USD 1.18 | USD 29,500 | SEC filing ↗ |
| 2024-08-15 | Tardugno Michael H | Purchase (P) | Imunon Common Stock | 25,000 | USD 1.03 | USD 25,750 | SEC filing ↗ |
| 2024-08-15 | Lindborg Stacy | Purchase (P) | Imunon Common Stock | 25,000 | USD 0.98 | USD 24,500 | SEC filing ↗ |
| 2022-04-12 | Tardugno Michael H | Purchase (P) | Celsion Corporation Common Stock | 4,000 | USD 3.53 | USD 14,120 | SEC filing ↗ |
| 2022-04-08 | Fritz Frederick J. | Purchase (P) | Celsion Corporation Common Stock | 5,000 | USD 4.05 | USD 20,250 | SEC filing ↗ |
| 2022-03-02 | Fritz Frederick J. | Purchase (P) | Celsion Corporation Common Stock | 2,000 | USD 4.69 | USD 9,380 | SEC filing ↗ |
| 2021-10-07 | Fritz Frederick J. | Purchase (P) | Celsion Corporation Common Stock | 20,000 | USD 0.88 | USD 17,600 | SEC filing ↗ |
| 2021-05-17 | Braun Donald P | Purchase (P) | Celsion Corporation Common Stock | 5,000 | USD 1.07 | USD 5,350 | SEC filing ↗ |
| 2020-02-28 | Martinez Alberto R Jr | Purchase (P) | Celsion Corporation Common Stock | 5,000 | USD 0.90 | USD 4,500 | SEC filing ↗ |
Form 4 evidence
53 transaction lines in the latest 365-day window; 73 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Tardugno Michael H | Award / grant (A) | Common Stock | 7,800 | USD 1.08 | USD 8,424 | SEC filing ↗ |
| 2026-10-09 | Lindborg Stacy | Award / grant (A) | Common Stock | 2,977 | USD 1.08 | USD 3,215 | SEC filing ↗ |
| 2026-10-09 | Faller Douglas Vincent | Award / grant (A) | Common Stock | 1,249 | USD 1.08 | USD 1,349 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Tardugno Michael H | Award / grant (A) | Common Stock | 7,800 | USD 1.08 | USD 8,424 | SEC filing ↗ |
| 2026-10-09 | Lindborg Stacy | Award / grant (A) | Common Stock | 2,977 | USD 1.08 | USD 3,215 | SEC filing ↗ |
| 2026-10-09 | Faller Douglas Vincent | Award / grant (A) | Common Stock | 1,249 | USD 1.08 | USD 1,349 | SEC filing ↗ |
| 2026-09-25 | Tardugno Michael H | Award / grant (A) | Common Stock | 7,169 | USD 1.41 | USD 10,108 | SEC filing ↗ |
| 2026-09-25 | Lindborg Stacy | Award / grant (A) | Common Stock | 6,697 | USD 1.41 | USD 9,443 | SEC filing ↗ |
| 2026-09-25 | Faller Douglas Vincent | Award / grant (A) | Common Stock | 4,390 | USD 1.41 | USD 6,190 | SEC filing ↗ |
| 2026-09-11 | Tardugno Michael H | Award / grant (A) | Common Stock | 5,824 | USD 1.47 | USD 8,561 | SEC filing ↗ |
| 2026-09-11 | Lindborg Stacy | Award / grant (A) | Common Stock | 5,504 | USD 1.47 | USD 8,091 | SEC filing ↗ |
| 2026-09-11 | Faller Douglas Vincent | Award / grant (A) | Common Stock | 4,211 | USD 1.47 | USD 6,190 | SEC filing ↗ |
| 2026-08-31 | Eylward Susan | Sale (S) | Common Stock | 2,525 | USD 1.56 | USD 3,939 | SEC filing ↗ |
| 2026-08-28 | Tardugno Michael H | Award / grant (A) | Common Stock | 7,371 | USD 1.60 | USD 11,794 | SEC filing ↗ |
| 2026-08-28 | Lindborg Stacy | Award / grant (A) | Common Stock | 6,822 | USD 1.60 | USD 10,915 | SEC filing ↗ |
| 2026-08-28 | Faller Douglas Vincent | Award / grant (A) | Common Stock | 3,626 | USD 1.60 | USD 5,802 | SEC filing ↗ |
| 2026-08-28 | Eylward Susan | Award / grant (A) | Common Stock | 2,525 | USD 1.60 | USD 4,040 | SEC filing ↗ |
| 2026-08-17 | Eylward Susan | Sale (S) | Common Stock | 2,449 | USD 1.63 | USD 3,992 | SEC filing ↗ |
| 2026-08-14 | Tardugno Michael H | Award / grant (A) | Common Stock | 7,147 | USD 1.65 | USD 11,793 | SEC filing ↗ |
| 2026-08-14 | Lindborg Stacy | Award / grant (A) | Common Stock | 6,615 | USD 1.65 | USD 10,915 | SEC filing ↗ |
| 2026-08-14 | Faller Douglas Vincent | Award / grant (A) | Common Stock | 3,516 | USD 1.65 | USD 5,801 | SEC filing ↗ |
| 2026-08-14 | Eylward Susan | Award / grant (A) | Common Stock | 2,449 | USD 1.65 | USD 4,041 | SEC filing ↗ |
| 2026-08-03 | Eylward Susan | Sale (S) | Common Stock | 2,541 | USD 1.57 | USD 3,989 | SEC filing ↗ |
| 2026-07-31 | Tardugno Michael H | Award / grant (A) | Common Stock | 6,358 | USD 1.59 | USD 10,109 | SEC filing ↗ |
| 2026-07-31 | Pellizzari Christine A | Award / grant (A) | Common Stock | 6,934 | USD 1.59 | USD 11,025 | SEC filing ↗ |
| 2026-07-31 | Lindborg Stacy | Award / grant (A) | Common Stock | 5,010 | USD 1.59 | USD 7,966 | SEC filing ↗ |
| 2026-07-31 | Fritz Frederick J. | Award / grant (A) | Common Stock | 6,934 | USD 1.59 | USD 11,025 | SEC filing ↗ |
| 2026-07-31 | Faller Douglas Vincent | Award / grant (A) | Common Stock | 3,649 | USD 1.59 | USD 5,802 | SEC filing ↗ |
| 2026-07-31 | Eylward Susan | Award / grant (A) | Common Stock | 2,541 | USD 1.59 | USD 4,040 | SEC filing ↗ |
| 2026-07-31 | Dentzer James E | Award / grant (A) | Common Stock | 6,934 | USD 1.59 | USD 11,025 | SEC filing ↗ |
| 2026-07-31 | Braun Donald P | Award / grant (A) | Common Stock | 6,180 | USD 1.59 | USD 9,826 | SEC filing ↗ |
| 2026-07-20 | Eylward Susan | Sale (S) | Common Stock | 2,150 | USD 1.78 | USD 3,827 | SEC filing ↗ |
| 2026-07-17 | Tardugno Michael H | Award / grant (A) | Common Stock | 4,603 | USD 1.83 | USD 8,423 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | IMNN |
| CIK | 0000749647 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 73 transaction lines from 2020-02-25 to 2026-10-09 9 P purchase lines · 6 S sale lines · 58 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.